Showing results (171-180 of 182) with videos related to
Sort By:
Pageof 19
Circulation|May 29, 2008
Phase 1b randomized study of antidote-controlled modulation of factor IXa activity in patients with stable coronary artery diseaseMark Y Chan, Mauricio G Cohen, Christopher K Dyke, et al.The American Journal of Medicine|July 15, 2015
Comparative Effectiveness of Statin Therapy in Chronic Kidney Disease and Acute Myocardial Infarction: A Retrospective Cohort StudyDavid H Smith, Eric S Johnson, Denise M Boudreau, et al.Archives of Internal Medicine|January 16, 2008
Incidence and prognostic significance of thrombocytopenia in patients treated with prolonged heparin therapyGustavo B F Oliveira, Eric M Crespo, Richard C Becker, et al.European Heart Journal|March 28, 2012
The relationship between CYP2C19 polymorphisms and ischaemic and bleeding outcomes in stable outpatients: the CHARISMA genetics studyDeepak L Bhatt, Guillaume Paré, John W Eikelboom, et al.JACC. Advances|March 24, 2026
Direct-to-Participant Enrollment in a Virtual Trial: Lessons Learned From the Heartline StudyMellanie True Hills, Serge Korjian, Gerald Chi, et al.American Heart Journal|September 20, 2005
A global view of atherothrombosis: baseline characteristics in the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trialDeepak L Bhatt, Keith A Fox, Werner Hacke, et al.Journal of the American College of Cardiology|May 15, 2007
Patients with prior myocardial infarction, stroke, or symptomatic peripheral arterial disease in the CHARISMA trialDeepak L Bhatt, Marcus D Flather, Werner Hacke, et al.The New England Journal of Medicine|March 15, 2006
Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic eventsDeepak L Bhatt, Keith A A Fox, Werner Hacke, et al.JAMA|July 9, 2004
Enoxaparin vs unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: primary results of the SYNERGY randomized trialJames J Ferguson, Robert M Califf, Elliott M Antman, et al.Circulation|February 28, 2018
2017 Cardiovascular and Stroke Endpoint Definitions for Clinical TrialsKaren A Hicks, Kenneth W Mahaffey, Roxana Mehran, et al.Pageof 19